V004-1363 Screening compound: 3-tert-butyl-1-{2-[1-(3,4-dichlorophenyl)-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazin-2-yl]-2-oxoethyl}-1-(propan-2-yl)urea

V004-1363 Screening compound: 3-tert-butyl-1-{2-[1-(3,4-dichlorophenyl)-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazin-2-yl]-2-oxoethyl}-1-(propan-2-yl)urea
V004-1363 Screening compound: 3-tert-butyl-1-{2-[1-(3,4-dichlorophenyl)-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazin-2-yl]-2-oxoethyl}-1-(propan-2-yl)urea alternative view

Chemical Structure Depiction of ChemDiv screening compound V004-1363
3-tert-butyl-1-{2-[1-(3,4-dichlorophenyl)-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazin-2-yl]-2-oxoethyl}-1-(propan-2-yl)urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V004-1363

Molecular Formula

C23H30Cl2N4O2 (C23 H30 Cl2 N4 O2)

Compound Name

3-tert-butyl-1-{2-[1-(3,4-dichlorophenyl)-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazin-2-yl]-2-oxoethyl}-1-(propan-2-yl)urea

IUPAC name

3-tert-butyl-1-{2-[1-(34-dichlorophenyl)-1H2H3H4H-pyrrolo[12-a]pyrazin-2-yl]-2-oxoethyl}-1-(propan-2-yl)urea

SMILES

CC(C)N(CC(N(CCn1c2ccc1)C2c(cc1)cc(Cl)c1Cl)=O)C(NC(C)(C)C)=O

InChI

InChI=1S/C23H30Cl2N4O2/c1-15(2)29(22(31)26-23(3,4)5)14-20(30)28-12-11-27-10-6-7-19(27)21(28)16-8-9-17(24)18(25)13-16/h6-10,13,15,21H,11-12,14H2,1-5H3,(H,26,31)/t21-/m1/s1

InChI Key

ISPKQBJZQMVLHH-OAQYLSRUSA-N

MDL Number (MFCD)

MFCD19798531

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

465.42

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.461

Distribution Coefficient, logD

5.461

Water Solubility, LogSw

-6.09

Polar Surface Area

43.298

Acid Dissociation Constant (pKa)

17.04

Base Dissociation Constant (pKb)

4.53

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.80

V004-1363 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with V004-1363 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V004-1363?
Check Price and Availability of V004-1363, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V004-1363 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V004-1363
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V004-1363
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V004-1363 available by request